ACCA SBR — Strategic Business Reporting Practice Exam 4

SECTION A

Background:
VerdantCorp is a multinational agri-tech company that prepares its consolidated financial statements in US Dollars ($) in accordance with IFRS. You are the group financial controller, and the financial year-end is 31 December 20X5.

Event 1: Acquisition of CropData
On 1 January 20X3, VerdantCorp acquired a 20% equity interest in CropData, a foreign company operating in the fictional country of Ozeria, for 15 million Ozerian Dinars (OZD). VerdantCorp exercised significant influence.
On 1 January 20X5, VerdantCorp acquired a further 55% of the equity shares in CropData for OZD 50 million, gaining control. On this date, the fair value of the original 20% interest was OZD 18 million. The fair value of the non-controlling interest (NCI) at acquisition was OZD 22 million. The fair value of CropData's identifiable net assets on 1 January 20X5 was OZD 70 million.
CropData's functional currency is the OZD. Goodwill is calculated using the full fair value method. Exchange rates (OZD to $1) are:

• 1 January 20X5: 2.0
• 31 December 20X5: 2.5
• Average for 20X5: 2.2

Event 2: Biological Assets
Included in CropData's net assets at acquisition were specialized genetically modified seed crops. Under local Ozerian GAAP, these were held at cost. For IFRS consolidation, VerdantCorp determined their fair value less costs to sell on 1 January 20X5 was OZD 10 million higher than their carrying amount. By 31 December 20X5, the fair value less costs to sell of these specific crops had increased by a further OZD 4 million.

Event 3: Intercompany Trading
During 20X5, VerdantCorp sold specialized drone farming equipment to CropData for $5 million. The equipment cost VerdantCorp $3 million to manufacture. CropData recorded the equipment as Property, Plant and Equipment (PPE) and depreciates it over 5 years on a straight-line basis. The transaction occurred on 1 July 20X5.

Requirements:
(a) Explain and calculate the goodwill arising on the acquisition of CropData on 1 January 20X5, detailing the accounting treatment of the step acquisition and the translation of goodwill into the presentation currency at year-end. (14 marks)
(b) Discuss the accounting treatment of the biological assets acquired, including the impact on the consolidated financial statements for the year ended 31 December 20X5. (8 marks)
(c) Prepare the necessary consolidation adjustment journals (in US Dollars) for the intercompany sale of the drone farming equipment as at 31 December 20X5. (8 marks)

SECTION A

Background:
AquaGrid is a publicly listed water utility company that is currently transitioning its operations toward renewable desalination plants. You are the Chief Accountant, an ACCA member. The financial year-end is 31 March 20X6.

Event 1: Decommissioning Provision
AquaGrid operates a legacy chemical treatment plant that is legally required to be dismantled in 5 years. The estimated cost of dismantling is $15 million. The CFO has instructed you to either delay recognizing this provision until the plant is actually closed, or to use an artificially high discount rate of 15% (the company's aggressive internal hurdle rate) rather than the risk-free rate of 4%, in order to minimize the liability on the balance sheet. The CFO explicitly stated, "We need to keep our debt-to-equity ratio low to avoid breaching our banking covenants this year."

Event 2: Government Grant
AquaGrid received a $10 million government grant on 1 January 20X6 to assist with the construction of a new solar-powered desalination plant. The grant stipulates that the plant must remain operational and maintain specific water output levels for 10 years; otherwise, the grant is fully repayable. Construction will take 2 years. The CFO wants to recognize the entire $10 million as income immediately in the current year's statement of profit or loss to boost earnings.

Requirements:
(a) Advise the CFO on the correct accounting treatment for the decommissioning provision (under IAS 37) and the government grant (under IAS 20) for the year ended 31 March 20X6. (10 marks)
(b) Discuss the ethical and professional issues you face as the Chief Accountant, and outline the actions you should take in accordance with the ACCA Code of Ethics and Conduct. (10 marks)

SECTION B

Background:
CloudNova is a fast-growing Software-as-a-Service (SaaS) technology startup preparing for an Initial Public Offering (IPO). The financial year-end is 31 December 20X5.

Event 1: Multi-element Revenue Contract
On 1 October 20X5, CloudNova signed a $1.2 million contract with a major enterprise client. The contract includes three components:

1. A perpetual software license.
2. Custom installation and deep integration of the software into the client's legacy IT systems.
3. Three years of post-contract customer support (PCS) and routine updates.
   The software cannot function without the custom installation, which only CloudNova can perform. The standalone selling price of the PCS is estimated at $300,000 for three years. The client paid the full $1.2 million upfront on 1 October 20X5.

Event 2: Share-Based Payments
To retain key executives ahead of the IPO, CloudNova granted 100,000 share options on 1 January 20X5. The options vest in three years (31 December 20X7) provided the executives remain employed by the company (a service condition) AND the company's share price reaches $50 within six months post-IPO (a market condition). The fair value of each option at the grant date was $12. By 31 December 20X5, management estimates that 10% of the executives will leave before vesting, but they believe the $50 share price target is highly unlikely to be met due to recent market downturns.

Event 3: Crypto Assets
CloudNova holds 50 Bitcoin, purchased for $2 million, as a long-term store of value. The company does not trade crypto assets in the ordinary course of business. The fair value at 31 December 20X5 is $3.5 million.

Requirements:
(a) Explain how CloudNova should recognize revenue from the multi-element contract for the year ended 31 December 20X5 in accordance with IFRS 15 Revenue from Contracts with Customers. (10 marks)
(b) Advise on the accounting treatment of the share-based payment scheme for the year ended 31 December 20X5 under IFRS 2, specifically addressing the impact of the different vesting conditions. (8 marks)
(c) Discuss how the crypto assets should be classified and measured under IFRS, and explain how potential IPO investors (stakeholders) might interpret the inclusion of such assets on the balance sheet. (7 marks)

SECTION B

Background:
AeroForge is a heavy manufacturing company specializing in aerospace components. The financial year-end is 31 December 20X5.

Event 1: Sale and Leaseback
On 1 January 20X5, AeroForge sold one of its manufacturing facilities to a real estate trust for $40 million and immediately leased it back for 10 years. The fair value of the facility at the date of sale was $35 million, and its carrying amount was $28 million. The transfer of the asset satisfies the requirements of IFRS 15 to be accounted for as a sale. The present value of the annual lease payments (discounted at the appropriate rate) is $25 million.

Event 2: Impairment of CGU
AeroForge has a specific division (a Cash Generating Unit - CGU) that manufactures parts for a commercial jet program that was recently cancelled. At 31 December 20X5, the carrying amounts of the CGU's assets are:

• Goodwill: $10 million
• Specialized Machinery (PPE): $40 million
• Inventory: $5 million
  The recoverable amount of the CGU as a whole is determined to be $38 million. The inventory's net realizable value is $4 million. The specialized machinery has no active secondary market, so its individual fair value less costs of disposal cannot be reliably estimated.

Event 3: Restructuring
Due to the cancelled jet program, the Board of Directors held a secret meeting on 20 December 20X5 and decided to close a factory associated with the division. A detailed formal plan was drafted. On 28 December 20X5, the Board informed the senior management team of the closure, but no public announcement was made, and the factory workers were not informed until 15 January 20X6. The estimated restructuring costs are $8 million.

Requirements:
(a) Detail the accounting treatment for the sale and leaseback transaction for the year ended 31 December 20X5, including the calculation of the right-of-use asset and the gain on rights transferred. (9 marks)
(b) Explain the principles of allocating an impairment loss to a CGU under IAS 36, and calculate the allocation of the impairment loss to the assets of the specific division. (8 marks)
(c) Discuss whether a restructuring provision should be recognized at 31 December 20X5 under IAS 37, and explain how lenders (stakeholders) would view the overall financial position of AeroForge given the events of the year. (8 marks)